Literature DB >> 21422140

Will Open Government make Canada's health agencies more transparent?

Paul C Hébert, Jane Coutts, Matthew B Stanbrook, Noni MacDonald, Ken Flegel.   

Abstract

Mesh：

Year:  2011        PMID： 21422140      PMCID： PMC3071379          DOI： 10.1503/cmaj.110411

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  The federal government's senseless policy change on tobacco warning labels.

Authors:  Matthew B Stanbrook; Paul C Hébert
Journal:  CMAJ       Date:  2010-11-08       Impact factor: 8.262

2.  Progressive drug licensing: an opportunity to achieve transparency and accountability?

Authors:  James M Wright
Journal:  CMAJ       Date:  2007-06-19       Impact factor: 8.262

Review 3.  Moving from opacity to transparency in pharmaceutical policy.

Authors:  Irfan Dhalla; Andreas Laupacis
Journal:  CMAJ       Date:  2008-02-12       Impact factor: 8.262

4.  Opening the gates on US government data.

Authors:  Lauren Vogel
Journal:  CMAJ       Date:  2011-03-21       Impact factor: 8.262

5.  Federal government unveils modest transparency initiative.

Authors:  Lauren Vogel
Journal:  CMAJ       Date:  2011-03-21       Impact factor: 8.262

6.  The secret's in: open data is a foreign concept in Canada.

Authors:  Lauren Vogel
Journal:  CMAJ       Date:  2011-03-14       Impact factor: 8.262
  6 in total
  1 in total

1.  Can Health Canada protect Canadians from unsafe drugs?

Authors:  Paul C Hébert; Matthew B Stanbrook; Noni MacDonald; Ken Flegel; Jane Coutts; Stuart MacLeod
Journal:  CMAJ       Date:  2011-04-18       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.